Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Portacci
Observed names:
A Portacci,
Portacci, Andrea
Institution:
University of Bari Aldo Moro
Observed institutions:
University of Pavia,
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari,
University of Bari Aldo Moro
ORCID:
0000-0002-6127-2486
Observed ORCID:
0000-0002-6127-2486
OpenAlex ID:
A5008755507
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
2021
·
Donato Lacedonia
, Giulia Scioscia
, et al.
·
Scientific Reports
·
58
PDF
Galectin-3 as prognostic biomarker in patients with COVID-19 acute respiratory failure
2021
·
Andrea Portacci
, Fabrizio Diaferia
, et al.
·
Respiratory Medicine
·
55
PDF
Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review
2024
·
Silvano Dragonieri
, Andrea Portacci
, et al.
·
Diseases
·
51
PDF
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
2023
·
Santi Nolasco
, Andrea Portacci
, et al.
·
Frontiers in Immunology
·
50
PDF
Switching Biological Therapies in Severe Asthma
2023
·
Giulia Scioscia
, Santi Nolasco
, et al.
·
International Journal of Molecular Sciences
·
49
PDF
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps
2023
·
Corrado Pelaia
, Alida Benfante
, et al.
·
Frontiers in Immunology
·
47
PDF
The right interface for the right patient in noninvasive ventilation: a systematic review
2022
·
Paola Pierucci
, Andrea Portacci
, et al.
·
Expert Review of Respiratory Medicine
·
45
Severe asthma clinical remission after biologic treatment with anti-IL4/IL13: A real-life experience
2023
·
Andrea Portacci
, Ilaria Iorillo
, et al.
·
Respiratory Medicine
·
40
PDF
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission
2024
·
Giovanna Elisiana Carpagnano
, Andrea Portacci
, et al.
·
Frontiers in Immunology
·
34
PDF
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
2023
·
Raffaele Campisi
, Santi Nolasco
, et al.
·
Journal of Clinical Medicine
·
32
PDF
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma”
2024
·
Giovanna Elisiana Carpagnano
, Andrea Portacci
, et al.
·
Journal of Clinical Medicine
·
29
PDF
Super-Responders to Biologic Treatment in Type 2–High Severe Asthma: Passing Fad or a Meaningful Phenotype?
2023
·
Andrea Portacci
, Silvano Dragonieri
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
29
Prolonged Active Prone Positioning in Spontaneously Breathing Non-intubated Patients With COVID-19-Associated Hypoxemic Acute Respiratory Failure With PaO2/FiO2 >150
2021
·
Paola Pierucci
, Nicolino Ambrosino
, et al.
·
Frontiers in Medicine
·
26
PDF
Effect of Food Intake on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose
2023
·
Silvano Dragonieri
, Vitaliano Nicola Quaranta
, et al.
·
Molecules
·
25
PDF
Advancing Care in Severe Asthma: The Art of Switching Biologics
2024
·
Silvano Dragonieri
, Andrea Portacci
, et al.
·
Advances in respiratory medicine
·
22
PDF
Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins
2025
·
Remo Poto
, Andrea Portacci
, et al.
·
Current Opinion in Allergy and Clinical Immunology
·
20
Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
2023
·
Andrea Portacci
, Raffaele Campisi
, et al.
·
ERJ Open Research
·
19
PDF
Dupilumab and Blood Eosinophilia: A Disease‐Specific Phenomenon?
2025
·
Andrea Portacci
, Remo Poto
, et al.
·
Allergy
·
18
PDF
Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study.
2023
·
Carla Santomasi
, Enrico Buonamico
, et al.
·
Acta bio-medica dell'Ateneo parmense/Acta biomedica
·
17
PDF
COVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy
2021
·
Andrea Portacci
, Giovanna Elisiana Carpagnano
, et al.
·
Expert Review of Respiratory Medicine
·
17
The Predictors of Long COVID in Southeastern Italy
2023
·
Vitaliano Nicola Quaranta
, Andrea Portacci
, et al.
·
Journal of Clinical Medicine
·
16
PDF
Patient's treatment burden related to care coordination in the field of respiratory diseases
2021
·
Paola Pierucci
, Carla Santomasi
, et al.
·
Breathe
·
16
PDF
Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study
2025
·
Alfredo Vozza
, Domenico Triggiani
, et al.
·
Frontiers in Endocrinology
·
15
PDF
The Role of Galectins in Asthma Pathophysiology: A Comprehensive Review
2024
·
Andrea Portacci
, Ilaria Iorillo
, et al.
·
Current Issues in Molecular Biology
·
13
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicenter study
2024
·
Giovanna Elisiana Carpagnano
, Silvano Dragonieri
, et al.
·
Journal of Asthma
·
11
Show more works
View as search
Works count:
127
Citation count:
920
H-index:
18
I10-index:
26
Year
Topic
Type